- Home
- KROS vs FINW Comparison
KROS vs FINW Comparison
Compare KROS & FINW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KROS | FINW |
|---|---|---|
| Founded | 2015 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 206.0M | 194.1M |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | KROS | FINW |
|---|---|---|
| Price | $11.31 | $13.56 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $21.86 | N/A |
| AVG Volume (30 Days) | ★ 159.2K | 18.4K |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 146.00 | 21.51 |
| EPS | N/A | ★ 0.35 |
| Revenue | ★ $243,864,000.00 | N/A |
| Revenue This Year | N/A | $160.48 |
| Revenue Next Year | $2,751.79 | $35.27 |
| P/E Ratio | ★ N/A | $39.56 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.69 | $12.82 |
| 52 Week High | $22.55 | $22.49 |
Technical Indicators
Market Signals| Indicator | KROS | FINW |
|---|---|---|
| Relative Strength Index (RSI) | 54.63 | 40.02 |
| Support Level | $10.57 | $13.15 |
| Resistance Level | $11.56 | $14.62 |
| Average True Range (ATR) | 0.48 | 0.39 |
| MACD | 0.01 | -0.03 |
| Stochastic Oscillator | 55.91 | 16.83 |
Price Performance
Historical ComparisonAbout KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About FINW FinWise Bancorp
FinWise Bancorp is an independent bank that provides a full range of banking services to individual and commercial customers. The bank's primary source of revenue is from loans, including Small Business Administration, commercial, commercial real estate, residential real estate, and consumer. The Bank has also established Strategic Programs with various third-party loan origination platforms that use technology to streamline the origination of unsecured consumer and secured or unsecured business loans to borrowers within certain approved credit profiles.